CHARLES UNIVERSITY IN PRAGUE

The aim of this Master thesis was to find out whether the rotating presidency of the Council of the European Union was able to exert influence in EU’s external relations after the Lisbon Treaty has entered into force. Thesis was looking on two post-Lisbon Council PresidenciesHungarian Council Presidency and the Polish Council Presidency and their influence in Eastern Partnership-the flagship initiative of both of these presidencies. Through the identification of the informal roles of the rotating presidency-agenda setter role and broker’s role, the influence on the development of Eastern Partnership of both Council Presidencies was determined. The other factors such as the reputation of the presiding country, stable domestic political situation, ability to deal with unexpected developments have been considered as important pre-requisites for the Council Presidency to be able to exert influence through its informal roles.

[1]  Ulrich Hounyo,et al.  Bootstrapping High-Frequency Jump Tests , 2018, Journal of the American Statistical Association.

[2]  C. Mohan,et al.  Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid , 2017, Front. Neurol..

[3]  Ondřej Benek.  Preparation and evaluation of potential drugs inhibiting mitochondrial enzymes , 2017 .

[4]  Terry K. Smith,et al.  Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer's disease treatment. , 2017, Bioorganic & medicinal chemistry.

[5]  P. Guest.  The identification and characterisation of novel inhibitors of the 17β-HSD10 enzyme for the treatment of Alzheimer's disease , 2016 .

[6]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[7]  P. Jendelová,et al.  Alzheimer’s Disease: Mechanism and Approach to Cell Therapy , 2015, International journal of molecular sciences.

[8]  L. Shimkets,et al.  Myxococcus CsgA, Drosophila Sniffer, and human HSD10 are cardiolipin phospholipases , 2015, Genes & development.

[9]  Paresh Date,et al.  A fast calibrating volatility model for option pricing , 2015, Eur. J. Oper. Res..

[10]  J. Orbie,et al.  A Fuzzy-Set Qualitative Comparative Analysis of the Hungarian, Polish and Lithuanian Presidencies and European Union Eastern Partnership Policies , 2015 .

[11]  Chi Seng Pun,et al.  Variance Swap with Mean Reversion, Multifactor Stochastic Volatility and Jumps , 2015, Eur. J. Oper. Res..

[12]  Laure Delcour,et al.  The EU’s Unexpected ‘Ideal Neighbour’? The Perplexing Case of Armenia’s Europeanisation , 2015 .

[13]  E. Raik.  The ‘Trio Presidency’ of the Council of the European Union: Towards More Continuity? , 2015 .

[14]  K. Kuča,et al.  Benzothiazoles - scaffold of interest for CNS targeted drugs. , 2015, Current medicinal chemistry.

[15]  B. Strooper,et al.  Lessons from a Failed γ-Secretase Alzheimer Trial , 2014, Cell.

[16]  Uwe Puetter.  The Rotating Council Presidency and the New Intergovernmentalism , 2014 .

[17]  A. Kaznowski.  Defying the Treaty: The Influence of the Polish and Lithuanian Council Presidencies on the Development of the Eastern Partnership. EU Diplomacy Paper No. 6, October 2014 , 2014 .

[18]  J. Vennix,et al.  ‘How to make the most of your time in the Chair’: EU presidencies and the management of Council debates , 2014 .

[19]  B. Kundu,et al.  Diversity‐Oriented Synthesis of Polycyclic Indoles: Brønsted or Lewis Acid Catalyzed Three‐Component Reaction for the Synthesis of α‐Carbolines and Pyrimidoindoles , 2014 .

[20]  C. Pinho,et al.  Mitochondrial import and degradation of amyloid-β peptide. , 2014, Biochimica et biophysica acta.

[21]  Benoît Sévi,et al.  Forecasting the volatility of crude oil futures using intraday data , 2014, Eur. J. Oper. Res..

[22]  M. Heneka,et al.  Truncated and modified amyloid-beta species , 2014, Alzheimer's Research & Therapy.

[23]  Xin Zhang,et al.  Generalized Autoregressive Score Model with Realized Measures of Volatility , 2014 .

[24]  N. Copsey,et al.  The Influence of Newer Member States in the European Union: The Case of Poland and the Eastern Partnership , 2014 .

[25]  F. Bossuyt,et al.  Assessing EU council presidencies: (Conditions for) success and influence , 2014 .

[26]  F. J. Luque,et al.  Exploring the structural basis of the selective inhibition of monoamine oxidase A by dicarbonitrile aminoheterocycles: role of Asn181 and Ile335 validated by spectroscopic and computational studies. , 2014, Biochimica et biophysica acta.

[27]  Hong Miao,et al.  Currency jumps, cojumps and the role of macro news , 2014 .

[28]  Abbas Ali Mahdi,et al.  Therapeutics of Alzheimer's disease: Past, present and future , 2014, Neuropharmacology.

[29]  S. Yan,et al.  Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction. , 2014, Current Alzheimer research.

[30]  C. Jack,et al.  Biomarker Modeling of Alzheimer’s Disease , 2013, Neuron.

[31]  M. Mišík.  Eastern Partnership and the Preferences of New EU Member States , 2013 .

[32]  Andreas K. Warntjen.  The Elusive Goal of Continuity? Legislative Decision-Making and the Council Presidency before and after Lisbon , 2013 .

[33]  Xinglong Wang,et al.  Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. , 2013, Free radical biology & medicine.

[34]  J. Orbie,et al.  Unpacking the influence of the council presidency on European Union external policies: the Polish council presidency and the eastern partnership , 2013 .

[35]  John R. Doyle,et al.  Patterns in stock market movements tested as random number generators , 2013, Eur. J. Oper. Res..

[36]  F. Heinemann,et al.  Synthesis of Differently Substituted tacn‐Based Ligands: Towards the Control of Solubility and Electronic and Steric Properties of Uranium Coordination Complexes , 2013 .

[37]  Naroa Marroquín-Martínez,et al.  Optimizing bounds on security prices in incomplete markets. Does stochastic volatility specification matter? , 2013, Eur. J. Oper. Res..

[38]  S. Yan,et al.  Structure‐Based Design and Synthesis of Benzothiazole Phosphonate Analogues with Inhibitors of Human ABAD‐Aβ for Treatment of Alzheimer’s Disease , 2013, Chemical biology & drug design.

[39]  Uwe Puetter,et al.  Consistency and diversity? The EU's rotating trio Council Presidency after the Lisbon Treaty , 2013 .

[40]  B. Penke,et al.  Intraneuronal β‐amyloid and its interactions with proteins and subcellular organelles , 2012, Electrophoresis.

[41]  Emmanuel Haven,et al.  De-noising option prices with the wavelet method , 2012, Eur. J. Oper. Res..

[42]  R. Ramsay.  Monoamine oxidases: the biochemistry of the proteins as targets in medicinal chemistry and drug discovery. , 2012, Current topics in medicinal chemistry.

[43]  K. Pomorska,et al.  Poland in the Driving Seat: A Mature Presidency in Turbulent Times , 2012 .

[44]  Nick C Fox,et al.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.

[45]  D. Poirier,et al.  Identification of a 17β‐Hydroxysteroid Dehydrogenase Type 10 Steroidal Inhibitor: A Tool to Investigate the Role of Type 10 in Alzheimer’s Disease and Prostate Cancer , 2012, ChemMedChem.

[46]  A. Ágh.  The Hungarian Rhapsodies: The Conflict of Adventurism and Professionalism in the European Union Presidency , 2012 .

[47]  J. Wiltfang,et al.  Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid‐β peptides , 2012, Proteomics. Clinical applications.

[48]  Thomas Meinl,et al.  A new wavelet-based denoising algorithm for high-frequency financial data mining , 2012, Eur. J. Oper. Res..

[49]  Jozef Baruník,et al.  Realized wavelet-based estimation of integrated variance and jumps in the presence of noise , 2012, 1202.1854.

[50]  M. Wolfe.  γ‐Secretase inhibitors and modulators for Alzheimer’s disease , 2012, Journal of neurochemistry.

[51]  Dimitrios P. Louzis,et al.  The Role of High Frequency Intra-Daily Data, Daily Range and Implied Volatility in Multi-Period Value-at-Risk Forecasting , 2011 .

[52]  Irene Bolea,et al.  Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease. , 2011, Journal of medicinal chemistry.

[53]  A. Contestabile.  The history of the cholinergic hypothesis , 2011, Behavioural Brain Research.

[54]  J. Ainge,et al.  Mitochondrial β-amyloid in Alzheimer's disease. , 2011, Biochemical Society transactions.

[55]  V. K. Rao,et al.  Synthesis, Antimicrobial, and Antioxidant Activity of New α-Aminophosphonates , 2011 .

[56]  Y. Yokoi,et al.  Synthesis of 2-Aminoindole-3-carboxylic Acid Derivatives by the Copper(I) Iodide Catalyzed Reaction of N-(2-Iodophenyl)formamides with Malononitrile or Cyanoacetates. , 2011 .

[57]  P. Wong,et al.  Amyloid precursor protein processing and Alzheimer's disease. , 2011, Annual review of neuroscience.

[58]  Anna L. Blobaum,et al.  Discovery, synthesis, and structure-activity relationship development of a series of N-(4-acetamido)phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu(4)) with CNS exposure in rats. , 2011, Journal of medicinal chemistry.

[59]  L. Lue,et al.  Inhibition of Amyloid-β (Aβ) Peptide-Binding Alcohol Dehydrogenase-Aβ Interaction Reduces Aβ Accumulation and Improves Mitochondrial Function in a Mouse Model of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[60]  Ding Li,et al.  Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as dual inhibitors for cholinesterases and amyloid beta aggregation. , 2011, Bioorganic & medicinal chemistry.

[61]  Chengjie Xiong,et al.  Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease , 2011, Alzheimer's Research & Therapy.

[62]  H. Chan,et al.  Synthesis, self-assembly, and charge transporting property of contorted tetrabenzocoronenes. , 2010, The Journal of organic chemistry.

[63]  P. Hansen,et al.  Realized GARCH: A Joint Model of Returns and Realized Measures of Volatility , 2010 .

[64]  G. Logroscino,et al.  REVIEW: γ‐Secretase Inhibitors for the Treatment of Alzheimer's Disease: The Current State , 2010, CNS neuroscience & therapeutics.

[65]  Luca Scorrano,et al.  An intimate liaison: spatial organization of the endoplasmic reticulum–mitochondria relationship , 2010, The EMBO journal.

[66]  J. Mak,et al.  (How) do norms guide Presidency behaviour in EU negotiations? , 2010 .

[67]  Yuyang Jiang,et al.  A Simple Copper-Catalyzed Cascade Synthesis of 2-Amino-1H-indole-3-carboxylate Derivatives , 2010 .

[68]  R. Maccioni,et al.  The revitalized tau hypothesis on Alzheimer's disease. , 2010, Archives of medical research.

[69]  Amélie Charles,et al.  The day-of-the-week effects on the volatility: The role of the asymmetry , 2010, Eur. J. Oper. Res..

[70]  P. Verhoest,et al.  Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties. , 2010, ACS chemical neuroscience.

[71]  Peter Reinhard Hansen,et al.  The Model Confidence Set , 2010 .

[72]  F. Gunn-Moore,et al.  The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease. , 2010, The Biochemical journal.

[73]  B. Bergmans,et al.  γ-secretases: from cell biology to therapeutic strategies , 2010, The Lancet Neurology.

[74]  Ana Fernandez.  The EU Council Presidency Dilemma: An Historical Institutionalist Interpretation , 2009 .

[75]  Stefan Gänzle.  EU Governance and the European Neighbourhood Policy: A Framework for Analysis , 2009 .

[76]  Ernst Schaumburg,et al.  Federal Reserve Bank of New York Staff Reports Jump-robust Volatility Estimation Using Nearest Neighbor Truncation Jump-robust Volatility Estimation Using Nearest Neighbor Truncation , 2010 .

[77]  Richard D. Taylor,et al.  Novel potent BRAF inhibitors: toward 1 nM compounds through optimization of the central phenyl ring. , 2009, Journal of medicinal chemistry.

[78]  Lili Zhang,et al.  γ‐secretase inhibitors for the treatment of Alzheimer's disease , 2009 .

[79]  S. Ohta,et al.  Cytoprotective role of mitochondrial amyloid β peptide-binding alcohol dehydrogenase against a cytotoxic aldehyde , 2009, Neurobiology of Aging.

[80]  Fulvio Corsi,et al.  A Simple Approximate Long-Memory Model of Realized Volatility , 2008 .

[81]  R. Katzman.,et al.  The Prevalence and Malignancy of Alzheimer Disease A Major Killer , 2008, Alzheimer's & Dementia.

[82]  Viviana Fernandez,et al.  Traditional versus novel forecasting techniques: how much do we gain? , 2008 .

[83]  K. Bennett,et al.  RNase P without RNA: Identification and Functional Reconstitution of the Human Mitochondrial tRNA Processing Enzyme , 2008, Cell.

[84]  B. Winblad,et al.  The amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae , 2008, Proceedings of the National Academy of Sciences.

[85]  D. Holtzman,et al.  ApoE Promotes the Proteolytic Degradation of Aβ , 2008, Neuron.

[86]  T. Bollerslev,et al.  A Reduced Form Framework for Modeling Volatility of Speculative Prices Based on Realized Variation Measures , 2008 .

[87]  Margaret A. Taylor,et al.  Endophilin I Expression Is Increased in the Brains of Alzheimer Disease Patients* , 2008, Journal of Biological Chemistry.

[88]  Michael McAleer,et al.  Realized Volatility: A Review , 2008 .

[89]  J. Lehmann,et al.  Synthesis and biological evaluation of NO-donor-tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates. , 2008, Journal of medicinal chemistry.

[90]  Maurizio Recanatini,et al.  Multi-target-directed ligands to combat neurodegenerative diseases. , 2008, Journal of medicinal chemistry.

[91]  George A. Christodoulakis,et al.  Common volatility and correlation clustering in asset returns , 2007, Eur. J. Oper. Res..

[92]  A. Cedazo-Mínguez,et al.  Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities , 2007, Journal of cellular and molecular medicine.

[93]  Kim N. Green,et al.  Intracellular amyloid-β in Alzheimer's disease , 2007, Nature Reviews Neuroscience.

[94]  Michael P. Mazanetz,et al.  Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases , 2007, Nature Reviews Drug Discovery.

[95]  Margaret A. Taylor,et al.  Interaction of amyloid binding alcohol dehydrogenase/Aβ mediates up-regulation of peroxiredoxin II in the brains of Alzheimer’s disease patients and a transgenic Alzheimer’s disease mouse model , 2007, Molecular and Cellular Neuroscience.

[96]  Markku Lanne,et al.  Forecasting realized exchange rate volatility by decomposition , 2007 .

[97]  G. Belfort,et al.  Surface plasmon resonance and nuclear magnetic resonance studies of ABAD-Abeta interaction. , 2007, Biochemistry.

[98]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[99]  E. Mandelkow,et al.  Structural Principles of Tau and the Paired Helical Filaments of Alzheimer’s Disease , 2007, Brain pathology.

[100]  José Marco-Contelles,et al.  Novel multipotent tacrine-dihydropyridine hybrids with improved acetylcholinesterase inhibitory and neuroprotective activities as potential drugs for the treatment of Alzheimer's disease. , 2006, Journal of medicinal chemistry.

[101]  Y. Long,et al.  4'-Alkoxyl substitution enhancing the anti-mitotic effect of 5-(3',4',5'-substituted)anilino-4-hydroxy-8-nitroquinazolines as a novel class of anti-microtubule agents. , 2006, Bioorganic & medicinal chemistry letters.

[102]  Jianqing Fan,et al.  Multi-Scale Jump and Volatility Analysis for High-Frequency Financial Data , 2006 .

[103]  Eric F. Johnson,et al.  Synthesis and SAR of indazole-pyridine based protein kinase B/Akt inhibitors. , 2006, Bioorganic & medicinal chemistry.

[104]  D. Landry,et al.  Identification of small-molecule inhibitors of the Abeta-ABAD interaction. , 2006, Bioorganic & medicinal chemistry letters.

[105]  Keith F. Tipton,et al.  The therapeutic potential of monoamine oxidase inhibitors , 2006, Nature Reviews Neuroscience.

[106]  Andrew J. Patton.  Volatility Forecast Comparison Using Imperfect Volatility Proxies , 2006 .

[107]  Gina N. LaRossa,et al.  Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans , 2006, Annals of neurology.

[108]  H. Pajouhesh,et al.  Medicinal chemical properties of successful central nervous system drugs , 2005, NeuroRX.

[109]  M. Beal,et al.  Mitochondria take center stage in aging and neurodegeneration , 2005, Annals of neurology.

[110]  Song-Yu Yang,et al.  Multiple functions of type 10 17β-hydroxysteroid dehydrogenase , 2005, Trends in Endocrinology & Metabolism.

[111]  R. Gencay,et al.  Multiscale systematic risk , 2005 .

[112]  P. Rejto,et al.  Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics. , 2004, Journal of molecular biology.

[113]  M. Mattson.  Pathways towards and away from Alzheimer's disease , 2004, Nature.

[114]  Xi Chen,et al.  Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A␤ to Mitochondrial Toxicity in Alzheimer's Disease , 2022 .

[115]  P. Hansen,et al.  A Forecast Comparison of Volatility Models: Does Anything Beat a Garch(1,1)? , 2004 .

[116]  J. Sass,et al.  2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: impaired catabolism of isoleucine presenting as neurodegenerative disease , 2004, Brain and Development.

[117]  P. Lansbury,et al.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.

[118]  K. Morgan,et al.  Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease. , 2003, The international journal of biochemistry & cell biology.

[119]  Song-Yu Yang,et al.  Oxidative 3α-hydroxysteroid dehydrogenase activity of human type 10 17β-hydroxysteroid dehydrogenase , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[120]  M N Rossor,et al.  The prevalence and causes of dementia in people under the age of 65 years , 2003, Journal of neurology, neurosurgery, and psychiatry.

[121]  Enrico Capobianco,et al.  Multiscale stochastic dynamics in finance , 2003, 2003 IEEE International Workshop on Workload Characterization (IEEE Cat. No.03EX775).

[122]  A. Lunde,et al.  Wavelet Estimation of Integrated Volatility , 2003 .

[123]  L. Thal,et al.  Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's disease , 2003, Journal of Neural Transmission.

[124]  R. Wanders,et al.  2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene. , 2003, American journal of human genetics.

[125]  P. Greengard,et al.  Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. , 2002, The American journal of pathology.

[126]  Wei Huang,et al.  Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease. , 2002, Journal of medicinal chemistry.

[127]  G. Lynch,et al.  Uptake and pathogenic effects of amyloid beta peptide 1–42 are enhanced by integrin antagonists and blocked by NMDA receptor antagonists , 2002, Neuroscience.

[128]  S. Park,et al.  A Practical and Convenient Procedure for the N‐Formylation of Amines Using Formic Acid. , 2002 .

[129]  N. Cairns,et al.  Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients , 2002, Neuroscience Letters.

[130]  K. Fischbeck,et al.  Toxic Proteins in Neurodegenerative Disease , 2002, Science.

[131]  Ronald J A Wanders,et al.  Clinical variability in 3‐hydroxy‐2‐methylbutyryl‐coa dehydrogenase deficiency , 2002, Annals of neurology.

[132]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[133]  James B. Ramsey,et al.  Wavelets in Economics and Finance: Past and Future , 2002 .

[134]  D. Lin,et al.  Abundant type 10 17 beta-hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimer's disease model. , 2002, Brain research. Molecular brain research.

[135]  Michael R. Chernick,et al.  Wavelet Methods for Time Series Analysis , 2001, Technometrics.

[136]  Lars Bertram,et al.  New Frontiers in Alzheimer's Disease Genetics , 2001, Neuron.

[137]  R. Gencay,et al.  An Introduction to Wavelets and Other Filtering Methods in Finance and Economics , 2001 .

[138]  Song-Yu Yang,et al.  Characterization and localization of human type10 17β-hydroxysteroid dehydrogenase , 2001 .

[139]  X. Tong,et al.  Endophilin Regulates JNK Activation through Its Interaction with the Germinal Center Kinase-like Kinase* , 2001, The Journal of Biological Chemistry.

[140]  R. Cowburn,et al.  Apolipoprotein E: a major piece in the Alzheimer's disease puzzle , 2001, Journal of cellular and molecular medicine.

[141]  F. Diebold,et al.  The distribution of realized stock return volatility , 2001 .

[142]  B. LeBaron,et al.  Stochastic volatility as a simple generator of apparent financial power laws and long memory , 2001 .

[143]  C. K. Liu,et al.  Apolipoprotein E polymorphism and Alzheimer's disease. , 2001, The Kaohsiung journal of medical sciences.

[144]  Francis X. Diebold,et al.  Modeling and Forecasting Realized Volatility , 2001 .

[145]  H. Dringenberg,et al.  Alzheimer's disease: more than a ‘cholinergic disorder' — evidence that cholinergic–monoaminergic interactions contribute to EEG slowing and dementia , 2000, Behavioural Brain Research.

[146]  M. Banfield,et al.  Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD). , 2000, Journal of molecular biology.

[147]  D. Small,et al.  Regulation of APP cleavage by α‐, β‐ and γ‐secretases , 2000 .

[148]  A. Walden,et al.  Statistical Properties and Uses of the Wavelet Variance Estimator for the Scale Analysis of Time Series , 2000 .

[149]  Jonathan D. Smith.  Apolipoprotein E4: an allele associated with many diseases , 2000, Annals of medicine.

[150]  T. Bayer,et al.  It all sticks together—the APP-related family of proteins and Alzheimer's disease , 1999, Molecular Psychiatry.

[151]  M. F. O'Shea,et al.  Behavioural status during the intracarotid amobarbital procedure (Wada test): relevance for surgical management , 1999, Journal of neurology, neurosurgery, and psychiatry.

[152]  I. Antoniou,et al.  Wavelets and stochastic processes , 1999 .

[153]  L. Tjernberg,et al.  Binding of amyloid β‐peptide to mitochondrial hydroxyacyl‐CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease , 1999 .

[154]  Song-Yu Yang,et al.  Human Brain Short Chain l-3-Hydroxyacyl Coenzyme A Dehydrogenase Is a Single-domain Multifunctional Enzyme , 1999, The Journal of Biological Chemistry.

[155]  W. Burke,et al.  Accumulation of 3,4-dihydroxyphenylglycolaldehyde, the neurotoxic monoamine oxidase A metabolite of norepinephrine, in locus ceruleus cell bodies in Alzheimer's disease: mechanism of neuron death , 1999, Brain Research.

[156]  Steven G. Clarke,et al.  Role of ERAB/l-3-Hydroxyacyl-coenzyme A Dehydrogenase Type II Activity in Aβ-induced Cytotoxicity* , 1999, The Journal of Biological Chemistry.

[157]  T. Bollerslev,et al.  ANSWERING THE SKEPTICS: YES, STANDARD VOLATILITY MODELS DO PROVIDE ACCURATE FORECASTS* , 1998 .

[158]  J. Brion,et al.  Neurofibrillary Tangles and Alzheimer’s Disease , 1998, European Neurology.

[159]  H. Willard,et al.  Chromosomal basis of X chromosome inactivation: identification of a multigene domain in Xp11.21-p11.22 that escapes X inactivation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[160]  Song-Yu Yang,et al.  A Human Brain l-3-Hydroxyacyl-coenzyme A Dehydrogenase Is Identical to an Amyloid β-Peptide-binding Protein Involved in Alzheimer’s Disease* , 1998, The Journal of Biological Chemistry.

[161]  E. Michaelis.  Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging , 1998, Progress in Neurobiology.

[162]  Xi Chen,et al.  An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease , 1997, Nature.

[163]  D. Percival,et al.  Analysis of Subtidal Coastal Sea Level Fluctuations Using Wavelets , 1997 .

[164]  Mark A. Smith,et al.  4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease , 1997, Journal of neurochemistry.

[165]  Allen D. Roses,et al.  A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer disease , 1997, Neurogenetics.

[166]  T. Hashimoto,et al.  Cloning and expression of cDNA for a newly identified isozyme of bovine liver 3-hydroxyacyl-CoA dehydrogenase and its import into mitochondria. , 1997, Biochimica et biophysica acta.

[167]  J. Cummings,et al.  Neuropsychiatric aspects of Alzheimer's disease , 1996, Neurology.

[168]  J. Fontecilla-Camps,et al.  The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors. , 1996, Structure.

[169]  G. Schellenberg,et al.  Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease , 1996, Nature Medicine.

[170]  T. Hashimoto,et al.  Two mitochondrial 3-hydroxyacyl-CoA dehydrogenases in bovine liver. , 1996, Journal of biochemistry.

[171]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[172]  H. Schulz,et al.  Short-chain 3-hydroxy-2-methylacyl-CoA dehydrogenase from rat liver: purification and characterization of a novel enzyme of isoleucine metabolism. , 1995, Archives of biochemistry and biophysics.

[173]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[174]  Yazhen Wang.  Jump and sharp cusp detection by wavelets , 1995 .

[175]  T Vogel,et al.  Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. , 1994, The American journal of pathology.

[176]  I. Johnstone,et al.  Ideal spatial adaptation by wavelet shrinkage , 1994 .

[177]  P. Watkins,et al.  Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. , 1994, JAMA.

[178]  Khadija Iqbal,et al.  Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. , 1993, The Journal of biological chemistry.

[179]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[180]  Ingrid Daubechies,et al.  Ten Lectures on Wavelets , 1992 .

[181]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[182]  C. Cotman,et al.  Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. , 1992, The Journal of biological chemistry.

[183]  L. Oreland,et al.  Monoamine oxidase B in brains from patients with Alzheimer's disease: A biochemical and autoradiographical study , 1991, Neuroscience.

[184]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[185]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[186]  M. Ball,et al.  Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease , 1983, Brain Research.

[187]  M. Esiri,et al.  Alzheimer's disease Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities , 1982, Journal of the Neurological Sciences.

[188]  R. Bartus,et al.  The cholinergic hypothesis of geriatric memory dysfunction. , 1982, Science.

[189]  J. Coyle,et al.  Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis , 1981, Annals of neurology.

[190]  Robert H. Perry,et al.  Neurotransmitter enzyme abnormalities in senile dementia Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue , 1977, Journal of the Neurological Sciences.

[191]  P. Davies,et al.  SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.

[192]  D M Bowen,et al.  Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. , 1976, Brain : a journal of neurology.

[193]  R. Castle,et al.  Cinnoline chemistry. IX. 5-, 6-, 7- and 8-halogen substituted 4-mercaptocinnolines and related compounds † , 1964 .

[194]  H. W. Dudley,et al.  The presence of histamine and acetylcholine in the spleen of the ox and the horse , 1929, The Journal of physiology.

[195]  Henry Dale,et al.  THE ACTION OF CERTAIN ESTERS AND ETHERS OF CHOLINE, AND THEIR RELATION TO MUSCARINE , 1914 .

[196]  Rhona K. M. Smith,et al.  Consolidated Version of the Treaty on the Functioning of the European Union , 2015 .

[197]  J. Jhamandas,et al.  Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. , 2013, Journal of psychiatry & neuroscience : JPN.

[198]  Asger Lunde,et al.  Modeling and Forecasting the Volatility of Energy Forward Returns-Evidence from the Nordic Power Exchange , 2013 .

[199]  Berat Beyza Aybat.  ANALYSIS OF SUCCESS ON THE EASTERN PARTNERSHIP , 2012 .

[200]  Agnieszka K. Cianciara.  ROTATING COUNCIL PRESIDENCY WITHIN THE POST-LISBON INSTITUTIONAL DYNAMICS: POLITICALLY IRRELEVANT? , 2012 .

[201]  V. Papadopoulos,et al.  Alzheimer's disease: effects of β-amyloid on mitochondria. , 2011, Mitochondrion.

[202]  H. Maurer,et al.  The Presidency in EU External Relations: Who is at the helm? , 2011 .

[203]  Drew D. Creal,et al.  Generalized Autoregressive Score Models with Applications ∗ , 2011 .

[204]  B. Vizi.  The Hungarian Presidency of the Council of the European Union: Focus on the Neighbourhood and on a European Roma Strategy , 2011 .

[205]  T. Bayer,et al.  Frontiers in Aging Neuroscience Aging Neuroscience Review Article Processing of the Amyloid Precursor Protein Generates Aβ Β Peptides , 2022 .

[206]  H. Maurer,et al.  The Council Presidency and European Foreign Policy - Challenges for Poland in 2011 , 2010 .

[207]  Dowgielewicz Mikolaj.  EXTERNAL CHALLENGES FOR THE POLISH PRESIDENCY IN THE COUNCIL OF THE EU , 2010 .

[208]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[209]  Fondation pour l’innovation politique Notre Europe.  Think Global - Act European: The Contribution of 14 European Think Tanks to the Spanish, Belgian and Hungarian Trio Presidency of the European Union , 2009 .

[210]  A. Bretteville,et al.  Tau aggregates: toxic, inert, or protective species? , 2008, Journal of Alzheimer's disease : JAD.

[211]  Petr Kaniok.  Předsednictví Rady EU: příběh půlstoletí , 2008 .

[212]  Jian Yang,et al.  Contagion Around the October 1987 Stock Market Crash , 2008, Eur. J. Oper. Res..

[213]  Research Division Federal Reserve Bank of St. Louis Working Paper Series Jumps, Cojumps and Macro Announcements , 2007 .

[214]  H. Anandatheerthavarada,et al.  Mitochondrial Translocation of Amyloid Precursor Protein and its Cleaved Products: Relevance to Mitochondrial Dysfunction in Alzheimer's Disease , 2007, Reviews in the neurosciences.

[215]  M. Beal.  Mitochondria and neurodegeneration. , 2007, Novartis Foundation symposium.

[216]  Ole Elgström.  The Presidency: The Role(s) of the Chair in European Union Negotiations. , 2006 .

[217]  Zhou Zhou,et al.  “A Tale of Two Time Scales: Determining Integrated Volatility with Noisy High-Frequency Data” , 2005 .

[218]  Jerry J Buccafusco,et al.  Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. , 2005, Trends in pharmacological sciences.

[219]  N. Hooper,et al.  Proteolytic mechanisms in amyloid-beta metabolism: therapeutic implications for Alzheimer's disease. , 2005, Trends in molecular medicine.

[220]  D. Selkoe,et al.  Natural oligomers of the amyloid-β protein specifically disrupt cognitive function , 2005, Nature Neuroscience.

[221]  O. Loewi.  Über humorale übertragbarkeit der Herznervenwirkung , 2005, Pflüger's Archiv für die gesamte Physiologie des Menschen und der Tiere.

[222]  P. Francis,et al.  Cholinesterase Inhibitors Used in the Treatment of Alzheimer’s Disease , 2004, Drugs & aging.

[223]  N. Shephard,et al.  Non‐Gaussian Ornstein–Uhlenbeck‐based models and some of their uses in financial economics , 2001 .

[224]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[225]  P. Greengard,et al.  Intraneuronal Aβ42 Accumulation in Human Brain , 2000 .

[226]  Song-Yu Yang,et al.  Intrinsic alcohol dehydrogenase and hydroxysteroid dehydrogenase activities of human mitochondrial short-chain L-3-hydroxyacyl-CoA dehydrogenase. , 2000, The Biochemical journal.

[227]  J. Shih,et al.  Monoamine oxidase: from genes to behavior. , 1999, Annual review of neuroscience.

[228]  D. Price,et al.  Mutant genes in familial Alzheimer's disease and transgenic models. , 1998, Annual review of neuroscience.

[229]  S. Mallat.  A wavelet tour of signal processing , 1998 .

[230]  D. Sparks,et al.  Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease, and Pick's disease. , 1991, Archives of neurology.

[231]  D. Selkoe,et al.  Microtubule-associated protein tau (? ) is a major antigenic component of paired helical filaments in Alzheimer disease , 1987 .

[232]  K. Grzeschik,et al.  The precursor of Alzheimer??s disease amyloid A4 protein resembles a cell-surface receptor , 1987 .

[233]  H. Wiśniewski,et al.  Abnormal phosphorylation of the microtubule-associated protein? (tau) in Alzheimer cytoskeletal pathology , 1987 .

[234]  Anders Liljas,et al.  2 Evolutionary and Structural Relationships among Dehydrogenases , 1975 .

[235]  A. Alzheimer.  Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .

[236]  M. Kirkitadze,et al.  Amyloid (cid:1) -protein (A (cid:1) ) assembly: A (cid:1) 40 and A (cid:1) 42 oligomerize through distinct pathways , 2002 .